Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells

A number of studies have shown pharmacologic evidence indicating that stimulation of type I dopamine receptor (DR), favors T-helper-17 (Th17)-mediated immunity involved in experimental autoimmune encephalomyelitis (EAE) and in some other inflammatory disorders. Nevertheless, the lack of drugs that m...

Full description

Bibliographic Details
Main Authors: Francisco Osorio-Barrios, Carolina Prado, Francisco Contreras, Rodrigo Pacheco
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2018.00192/full
_version_ 1818241860624187392
author Francisco Osorio-Barrios
Carolina Prado
Francisco Contreras
Rodrigo Pacheco
Rodrigo Pacheco
author_facet Francisco Osorio-Barrios
Carolina Prado
Francisco Contreras
Rodrigo Pacheco
Rodrigo Pacheco
author_sort Francisco Osorio-Barrios
collection DOAJ
description A number of studies have shown pharmacologic evidence indicating that stimulation of type I dopamine receptor (DR), favors T-helper-17 (Th17)-mediated immunity involved in experimental autoimmune encephalomyelitis (EAE) and in some other inflammatory disorders. Nevertheless, the lack of drugs that might discriminate between DRD1 and DRD5 has made the pharmacological distinction between the two receptors difficult. We have previously shown genetic evidence demonstrating a relevant role of DRD5-signaling in dendritic cells (DCs) favoring the CD4+ T-cell-driven inflammation in EAE. However, the role of DRD5-signaling confined to CD4+ T-cells in the development of EAE is still unknown. Here, we analyzed the functional role of DRD5-signaling in CD4+ T-cell-mediated responses and its relevance in EAE by using a genetic approach. Our results show that DRD5-signaling confined to naive CD4+ T-cells exerts a pro-inflammatory effect promoting the development of EAE with a stronger disease severity. This pro-inflammatory effect observed for DRD5-signaling in naive CD4+ T-cells was related with an exacerbated proliferation in response to T-cell activation and to an increased ability to differentiate toward the Th17 inflammatory phenotype. On the other hand, quite unexpected, our results show that DRD5-signaling confined to Tregs strengthens their suppressive activity, thereby dampening the development of EAE manifestation. This anti-inflammatory effect of DRD5-signaling in Tregs was associated with a selective increase in the expression of glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR), which has been described to play a critical role in the expansion of Tregs. Our findings here indicate a complex role for DRD5-signaling in CD4+ T-cells-driven responses potentiating early inflammation mediated by effector T-cells in EAE, but exacerbating suppressive activity in Tregs and thereby dampening disease manifestation in late EAE stages.
first_indexed 2024-12-12T13:36:03Z
format Article
id doaj.art-5089f187f87d479296f95afa304f0a92
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-12-12T13:36:03Z
publishDate 2018-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-5089f187f87d479296f95afa304f0a922022-12-22T00:22:56ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022018-07-011210.3389/fncel.2018.00192366189Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-CellsFrancisco Osorio-Barrios0Carolina Prado1Francisco Contreras2Rodrigo Pacheco3Rodrigo Pacheco4Laboratorio de Neuroinmunología, Fundación Ciencia & Vida, Santiago, ChileLaboratorio de Neuroinmunología, Fundación Ciencia & Vida, Santiago, ChileLaboratorio de Neuroinmunología, Fundación Ciencia & Vida, Santiago, ChileLaboratorio de Neuroinmunología, Fundación Ciencia & Vida, Santiago, ChileDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, ChileA number of studies have shown pharmacologic evidence indicating that stimulation of type I dopamine receptor (DR), favors T-helper-17 (Th17)-mediated immunity involved in experimental autoimmune encephalomyelitis (EAE) and in some other inflammatory disorders. Nevertheless, the lack of drugs that might discriminate between DRD1 and DRD5 has made the pharmacological distinction between the two receptors difficult. We have previously shown genetic evidence demonstrating a relevant role of DRD5-signaling in dendritic cells (DCs) favoring the CD4+ T-cell-driven inflammation in EAE. However, the role of DRD5-signaling confined to CD4+ T-cells in the development of EAE is still unknown. Here, we analyzed the functional role of DRD5-signaling in CD4+ T-cell-mediated responses and its relevance in EAE by using a genetic approach. Our results show that DRD5-signaling confined to naive CD4+ T-cells exerts a pro-inflammatory effect promoting the development of EAE with a stronger disease severity. This pro-inflammatory effect observed for DRD5-signaling in naive CD4+ T-cells was related with an exacerbated proliferation in response to T-cell activation and to an increased ability to differentiate toward the Th17 inflammatory phenotype. On the other hand, quite unexpected, our results show that DRD5-signaling confined to Tregs strengthens their suppressive activity, thereby dampening the development of EAE manifestation. This anti-inflammatory effect of DRD5-signaling in Tregs was associated with a selective increase in the expression of glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR), which has been described to play a critical role in the expansion of Tregs. Our findings here indicate a complex role for DRD5-signaling in CD4+ T-cells-driven responses potentiating early inflammation mediated by effector T-cells in EAE, but exacerbating suppressive activity in Tregs and thereby dampening disease manifestation in late EAE stages.https://www.frontiersin.org/article/10.3389/fncel.2018.00192/fullTh17 responseT-cell activationregulatory T-cellsdopamineknockout miceexperimental autoimmune encephalomyelitis
spellingShingle Francisco Osorio-Barrios
Carolina Prado
Francisco Contreras
Rodrigo Pacheco
Rodrigo Pacheco
Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
Frontiers in Cellular Neuroscience
Th17 response
T-cell activation
regulatory T-cells
dopamine
knockout mice
experimental autoimmune encephalomyelitis
title Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
title_full Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
title_fullStr Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
title_full_unstemmed Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
title_short Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells
title_sort dopamine receptor d5 signaling plays a dual role in experimental autoimmune encephalomyelitis potentiating th17 mediated immunity and favoring suppressive activity of regulatory t cells
topic Th17 response
T-cell activation
regulatory T-cells
dopamine
knockout mice
experimental autoimmune encephalomyelitis
url https://www.frontiersin.org/article/10.3389/fncel.2018.00192/full
work_keys_str_mv AT franciscoosoriobarrios dopaminereceptord5signalingplaysadualroleinexperimentalautoimmuneencephalomyelitispotentiatingth17mediatedimmunityandfavoringsuppressiveactivityofregulatorytcells
AT carolinaprado dopaminereceptord5signalingplaysadualroleinexperimentalautoimmuneencephalomyelitispotentiatingth17mediatedimmunityandfavoringsuppressiveactivityofregulatorytcells
AT franciscocontreras dopaminereceptord5signalingplaysadualroleinexperimentalautoimmuneencephalomyelitispotentiatingth17mediatedimmunityandfavoringsuppressiveactivityofregulatorytcells
AT rodrigopacheco dopaminereceptord5signalingplaysadualroleinexperimentalautoimmuneencephalomyelitispotentiatingth17mediatedimmunityandfavoringsuppressiveactivityofregulatorytcells
AT rodrigopacheco dopaminereceptord5signalingplaysadualroleinexperimentalautoimmuneencephalomyelitispotentiatingth17mediatedimmunityandfavoringsuppressiveactivityofregulatorytcells